• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
 
Generic Name:  avatrombopag maleate
Trade Name:  
Date Designated:  09/01/2011
Orphan Designation:  Treatment of idiopathic thrombocytopenic purpura
Orphan Designation Status:  Designated/Approved
Marketing Approval Date:  06/26/2019 
Approved Labeled Indication:  DOPTELET is indicated for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment
Exclusivity End Date:    06/26/2026 
Exclusivity Protected Indication* :  For the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment
Dova Pharmaceuticals, Inc.
240 Leigh Farm Road
Suite 245
Durham, North Carolina 27707
United States

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.
-
-